世界の肺炎球菌ワクチン市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC08419)
◆英語タイトル:Global Pneumococcal Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC08419
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、肺炎球菌ワクチンの世界市場を調査対象にし、肺炎球菌ワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(PPSV 23、PCV 7/13、PCV 10)、用途別分析(子供、大人)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Pfizer、Sanofipasteur、GSK、MSD、CDIBP
・メーカー別販売量、売上、市場シェア
・肺炎球菌ワクチンの地域別市場分析
・肺炎球菌ワクチンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・肺炎球菌ワクチンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・肺炎球菌ワクチンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・肺炎球菌ワクチンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・肺炎球菌ワクチンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・肺炎球菌ワクチンの種類別市場規模2015-2020:PPSV 23、PCV 7/13、PCV 10
・肺炎球菌ワクチンの用途別市場規模2015-2020:子供、大人
・肺炎球菌ワクチンの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019.

Market segmentation
Pneumococcal Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pneumococcal Vaccine market has been segmented into
PPSV 23
PCV 7/13
PCV 10

By Application, Pneumococcal Vaccine has been segmented into:
Child
Adult

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumococcal Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumococcal Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumococcal Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Pneumococcal Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Pneumococcal Vaccine Market Share Analysis
Pneumococcal Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumococcal Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumococcal Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Pneumococcal Vaccine are:
Pfizer
Sanofipasteur
GSK
MSD
CDIBP

Among other players domestic and global, Pneumococcal Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine in 2018 and 2019.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Child
1.3.3 Adult
1.4 Overview of Global Pneumococcal Vaccine Market
1.4.1 Global Pneumococcal Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofipasteur
2.2.1 Sanofipasteur Details
2.2.2 Sanofipasteur Major Business
2.2.3 Sanofipasteur SWOT Analysis
2.2.4 Sanofipasteur Product and Services
2.2.5 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MSD
2.4.1 MSD Details
2.4.2 MSD Major Business
2.4.3 MSD SWOT Analysis
2.4.4 MSD Product and Services
2.4.5 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business
2.5.3 CDIBP SWOT Analysis
2.5.4 CDIBP Product and Services
2.5.5 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.4 France Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.5 India Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Pneumococcal Vaccine Price by Type (2015-2020)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Pneumococcal Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pneumococcal Vaccine Market Forecast (2021-2025)
12.3 Pneumococcal Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
12.4 Pneumococcal Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肺炎球菌ワクチン市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Pneumococcal Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。